Market Value4,191,251,943
Total Holdings121
File Date2023-05-15
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
KNTE / Kinnate Biopharma Inc.
BHVN / Biohaven Ltd.
FOLD / Amicus Therapeutics, Inc.
ALGN / Align Technology, Inc.
INVA / Innoviva, Inc.
ZLAB / Zai Lab Limited - Depositary Receipt (Common Stock)
AGL / agilon health, inc.
ANAB / AnaptysBio, Inc.
BMEA / Biomea Fusion, Inc.
CINC / CinCor Pharma Inc
OLK / Olink Holding AB (publ) - Depositary Receipt (Common Stock)
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
ISRG / Intuitive Surgical, Inc.
HUM / Humana Inc.
TLPH / Talphera, Inc.
US64125CAD11 / Neurocrine Bios Bond
US761299AB20 / Retrophin Inc Bond
SPRB / Spruce Biosciences, Inc.
EXAS / Exact Sciences Corporation
PEN / Penumbra, Inc.
HZNP / Horizon Therapeutics Plc
VINC / Vincerx Pharma, Inc.
MGNX / MacroGenics, Inc.
TVTX / Travere Therapeutics, Inc.
AMLX / Amylyx Pharmaceuticals, Inc.
WRBY / Warby Parker Inc.
PRTA / Prothena Corporation plc
INZY / Inozyme Pharma, Inc.
BCEL / Atreca, Inc.
RXDX / Prometheus Biosciences Inc
CERE / Cerevel Therapeutics Holdings, Inc.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
IRTC / iRhythm Technologies, Inc.
MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock)
CMPX / Compass Therapeutics, Inc.
MRSN / Mersana Therapeutics, Inc.
PODD / Insulet Corporation
LUNG / Pulmonx Corporation
XLV / The Select Sector SPDR Trust - The Health Care Select Sector SPDR Fund
EVH / Evolent Health, Inc.
IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock)
US38341PAA03 / Gossamer Bio Inc
FSTX / F-star Therapeutics Inc
BAX / Baxter International Inc.
COLL / Collegium Pharmaceutical, Inc.
AKRO / Akero Therapeutics, Inc.
APLT / Applied Therapeutics, Inc.
MDGL / Madrigal Pharmaceuticals, Inc.
HCAT / Health Catalyst, Inc.
GH / Guardant Health, Inc.
ARGX / argenx SE - Depositary Receipt (Common Stock)
VERV / Verve Therapeutics, Inc.
KDNY / Chinook Therapeutics Inc
US03217L1061 / Amryt Pharma PLC Sponsored ADR (United Kingdom)
EPIX / ESSA Pharma Inc.
LFST / LifeStance Health Group, Inc.
CYTK / Cytokinetics, Incorporated
RVMD / Revolution Medicines, Inc.
US64157FAC77 / Nevro Corp
LEGN / Legend Biotech Corporation - Depositary Receipt (Common Stock)
PCRX / Pacira BioSciences, Inc.
DVAX / Dynavax Technologies Corporation
BMRN / BioMarin Pharmaceutical Inc.
IDXX / IDEXX Laboratories, Inc.
ACCD / Accolade, Inc.
AURA / Aura Biosciences, Inc.
FATE / Fate Therapeutics, Inc.
AGLE / Aeglea BioTherapeutics Inc
ETNB / 89bio, Inc. Call
CLDX / Celldex Therapeutics, Inc.
IRON / Disc Medicine, Inc.
ICVX / Icosavax, Inc.
PHR / Phreesia, Inc.
RLAY / Relay Therapeutics, Inc.
XENE / Xenon Pharmaceuticals Inc.
LPTX / Leap Therapeutics, Inc.
MRTX / Mirati Therapeutics, Inc.
WST / West Pharmaceutical Services, Inc.
NVAX / Novavax, Inc.
CGEN / Compugen Ltd.
UNH / UnitedHealth Group Incorporated
AGIO / Agios Pharmaceuticals, Inc.
KYMR / Kymera Therapeutics, Inc.
EDAP / EDAP TMS S.A. - Depositary Receipt (Common Stock)
NBIX / Neurocrine Biosciences, Inc.
EW / Edwards Lifesciences Corporation
SRPT / Sarepta Therapeutics, Inc.
GMDA / Gamida Cell Ltd.
RARE / Ultragenyx Pharmaceutical Inc.
RYTM / Rhythm Pharmaceuticals, Inc.
GOSS / Gossamer Bio, Inc.
XLO / Xilio Therapeutics, Inc.
DXCM / DexCom, Inc.
PRTK / Paratek Pharmaceuticals Inc.
ABCZF / Abcam Limited
AUPH / Aurinia Pharmaceuticals Inc.
NVCR / NovoCure Limited
KRTX / Karuna Therapeutics, Inc.
NUVB.WS / Panacea Acquisition Corp. - Equity Warrant
CNMD / CONMED Corporation
FULC / Fulcrum Therapeutics, Inc.
ALT / Altimmune, Inc.
MIRM / Mirum Pharmaceuticals, Inc.
TPST / Tempest Therapeutics, Inc.
DSGN / Design Therapeutics, Inc.
IMTX / Immatics N.V.
FRPT / Freshpet, Inc.
PLRX / Pliant Therapeutics, Inc.
AZTA / Azenta, Inc.
BCRX / BioCryst Pharmaceuticals, Inc.
BEAM / Beam Therapeutics Inc.
ALNY / Alnylam Pharmaceuticals, Inc.
ACHC / Acadia Healthcare Company, Inc.
MLYS / Mineralys Therapeutics, Inc.
SWAV / Shockwave Medical, Inc.
RPHM / Reneo Pharmaceuticals, Inc.
SGEN / Seagen Inc
VIGL / Vigil Neuroscience, Inc.
NKTX / Nkarta, Inc.
NVTAQ / Invitae Corporation
SPRO / Spero Therapeutics, Inc.
NVRO / Nevro Corp.
ACRS / Aclaris Therapeutics, Inc.
BPMC / Blueprint Medicines Corporation